Drug
Gc101 Adeno Associated Virus
Gc101 Adeno Associated Virus: highest development phase Phase 3, developed by GeneCradle Inc. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- GeneCradle Inc
Trials
| Drug | Phase | Indication |
|---|---|---|
| GC101 adeno-associated virus injection NCT06971094 | Phase 3 | SMA - Spinal Muscular Atrophy |
Latest
No recent events.
Follow Gc101 Adeno Associated Virus on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.